ReviewFrontiers in oncology2022
Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer.
Xiling Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled ittrialcites it
ReviewFrontiers in oncology2022
Xiling Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.